LightNews — News, ranked by scholars

OncoDaily

@oncodaily.bsky.social

ADC Target Expression and Interstitial Lung Disease in NSCLC - Vivek Subbiah

https://oncodaily.com/insight/194410

viveksubbiah.bsky.social solangepeters.bsky.social

##Antibody ##AntibodyDrugConjugate ##Cancer ##InterstitialLungDisease ##Lungdisease ##NSCLC ##OncoDaily ##Oncology

Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC - OncoDaily

Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC / Aakash Desai, Ajay Sheshadri, antibody, antibody-drug conjugate, cancer,

oncodaily.com

December 3, 2024 at 11:00 AM

OncoDaily

@oncodaily.bsky.social

Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC

https://oncodaily.com/drugs/sacituzumab-193201

##AntibodyDrugConjugate ##Cancer ##ChinasNationalMedicalProductsAdministration ##NMPA ##OncoDaily ##Oncology ##Sacituzumab ##Tirumotecan

Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC - OncoDaily

Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC / antibody-drug conjugate, cancer, China's National Medical Products

oncodaily.com

December 3, 2024 at 9:01 AM

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

#oncology #resistantovariancancer #ovariancancer #mirvetuximabsoravtansine #Elahere #AbbVie #antibodydrugconjugate #ADC #epithelialovariancancer #fallopiantubecancer #primaryperitonealcancer #folatereceptoralphapositiveovariancancer #MIRASOLstudy #CancerDrugsFund
zurl.co/3c2Cw

First new NHS treatment in over 20 years recommended for women with resistant ovarian cancer

NICE recommends new treatment for resistant ovarian cancer

www.nice.org.uk

June 5, 2026 at 9:06 AM

Antibody Therapeutics

@antibodytx.bsky.social

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Review Highlight -Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors.
doi.org/10.1093/abt/...
#adc #antibodydrugconjugate #adcs #antibodydrugconjugates #toxicity

September 23, 2026 at 1:36 PM

Antibody Therapeutics

@antibodytx.bsky.social

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Review Highlight -The evolving landscape of enzymatic technologies for precision synthesis of antibody–drug conjugates.
doi.org/10.1093/abt/...
#antibodydrugconjugate #adcs #antibodydrugconjugates #adpribosylcyclase #cd38

September 18, 2026 at 2:03 PM

Onco404

@onco404.bsky.social

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌

Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.

#Onco404 #Cancer #Kanser #MedSky #AntibodyDrugConjugate #ADC #Enhertu #Trodelvy #Padcev #Kadcyla #Elahere #Mylotarg #Polivy #Vocabulary

May 15, 2025 at 8:00 AM

ONCOassist® | The go-to oncology app

@oncoassist.bsky.social

ONCOassist Universal Link

Opening ONCOassist app...

bit.ly

March 9, 2026 at 1:00 PM

ESMO - European Society for Medical Oncology

@myesmo.bsky.social

#ESMOBreast25: Phase 1 trial data highlights preliminary efficacy and manageable safety of B7-H4–targeted #AntibodyDrugConjugate in women receiving at least one prior topoisomerase-1 #ADC.

Read the full article in the #ESMODailyReporter

🔗 buff.ly/nHI7BbH

May 20, 2025 at 12:30 PM

The Pharmaceutical Journal

@pharmaj.bsky.social

#RachelBrazil examines progress by researchers to create a new generation of antibody drug conjugates to improve efficacy and minimise off-target adverse effects of these cancer therapies
#Enhertu #enfortumabvedotin #antibodydrugconjugate

Engineering precision: developing the next generation of antibody drug conjugates

When results from the ‘EV-302’ bladder cancer trial were presented at the European Society for Medical Oncology annual meeting in October 2023, they received a standing ovation. The study compared…

buff.ly

January 16, 2025 at 8:30 AM

The Pharmaceutical Journal

@pharmaj.bsky.social

In this week's feature, #RachelBrazil examines a new generation of antibody drug conjugates that have been found to improve efficacy and minimise off-target adverse effects of cancer therapies

#Enhertu #enfortumabvedotin #antibodydrugconjugate

Engineering precision: developing the next generation of antibody drug conjugates

When results from the ‘EV-302’ bladder cancer trial were presented at the European Society for Medical Oncology annual meeting in October 2023, they received a standing ovation. The study compared…

buff.ly

January 19, 2025 at 6:00 PM

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

#biotech #Venturefinancing #BioindustryAssociation #IsomorphicLabs #venturecapital #privateinvestment #startups #unicorns #MandA #mergersandacquisitions #Novartis #antibodydrugconjugate #ADC #MyricxBio #IPO #publicmarkets #Oncology #Financing #BIA #UK
zurl.co/faX6P

UK biotech venture investment remains buoyant in Q2

Venture financing for UK biotechs reached a five-year high in the second quarter of the year, with more than £2 billion raised, says BIA.

pharmaphorum.com

July 20, 2026 at 12:17 PM

Antibody Therapeutics

@antibodytx.bsky.social

Antibody Therapeutics (IF=4.5, Oxford University Press) ⚡ Review Highlight -Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate
academic.oup.com/abt/article/...
#solidtumors #tumorpenetration #singledomainantibody #antibodydrugconjugate

Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate

Statement of Significance: The research on ADCs is advancing toward an innovative transitional phase. Small antibody fragments or other structurally derive

academic.oup.com

June 7, 2026 at 4:05 PM

Antibody Therapeutics

@antibodytx.bsky.social

Antibody Therapeutics (IF=4.5, Oxford University Press) ⚡ Review Highlight -The Evolving Landscape of Enzymatic Technologies for Precision Synthesis of Antibody-Drug Conjugates
academic.oup.com/abt/advance-...
#antibodydrugconjugate #antibodydrugconjugates #adpribosylcyclase #cd38

The evolving landscape of enzymatic technologies for precision synthesis of antibody–drug conjugates

Statement of Significance This work reviews currently established enzymatic approaches for generating homogeneous antibody–drug conjugates (ADCs) with defi

academic.oup.com

June 6, 2026 at 12:14 PM

Georgian Medical Journal (GMJ)

@gmj-georgia.bsky.social

Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a…

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Sm…

ABBV-706 Phase 1 Trial Correction Published

Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a… #ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer

news.gmj.ge

September 14, 2026 at 7:26 AM

Georgian Medical Journal (GMJ)

@gmj-georgia.bsky.social

Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a…

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Sm…

ABBV-706 Phase 1 Trial Correction Published

Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a… #ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer

news.gmj.ge

September 3, 2026 at 10:41 AM

OncLive

@onclive.bsky.social

🧬🎯 Trastuzumab rezetecan demonstrated high objective response rates in patients with HER2-high and HER2-low salivary gland carcinoma.
Read more ➡️ www.onclive.com/view/trastuz...
#SalivaryGlandCancer #HER2 #ADC #AntibodyDrugConjugate #TargetedTherapy #PrecisionOncology #HeadAndNeckCancer #Oncology

Trastuzumab Rezetecan Elicits High ORR in HER2-High and HER2-Low Salivary Gland Carcinoma | OncLive

The HER2-directed ADC produced confirmed responses across both biomarker-defined cohorts of advanced salivary gland carcinoma.

www.onclive.com

August 14, 2026 at 1:27 PM

Antibody Therapeutics

@antibodytx.bsky.social

Antibody Therapeutics (IF=4.5, Oxford University Press) ⚡ Research Highlight - "Novel ADC and γδ T cell engager targeting CDH17 for the therapy of gastrointestinal cancers"
doi.org/10.1093/abt/...
#antibody #antibodydrugconjugate #tcellengager #gammadeltatcells #immunotherapy

Novel ADC and γδ T cell engager targeting CDH17 for the therapy of gastrointestinal cancers

Statement of Significance We developed two novel complementary therapeutic modalities targeting an emerging gastrointestinal tumor-associated antigen, CDH1

doi.org

August 6, 2026 at 9:49 PM

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

#biotech #GSK #Nuvalent #MandA #GSK #Nuvalent #Oncology #lungcancer #antibodydrugconjugate #ADC #ALKinhibitor #NSCLC #ROS1positiveNSCLC #ALKpositiveNSCLC #RAPTTherapeutics #Liverfibrosis #Engitix #liverfibrosis #Hepatology #BostonTherapeutics #SLD #chronichepatitisBtherapy
zurl.co/6i8wS

GSK pursues $10.6bn takeover of cancer biotech Nuvalent

GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.

zurl.co

June 10, 2026 at 11:54 AM

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

#oncology #AbbVie #solidtumourtherapies #ADCs #antibodydrugconjugate #ADCplatform #solidtumours #ESMO2025 #pancreaticcancer #colorectalcancer #solidtumourtypes #ADCcandidates #clinicaldevelopment #innovativetherapies #patientoutcomes #clinicalstrategies #regulatory
zurl.co/AmIT3

AbbVie unveils new data on solid tumour therapies - PharmaTimes

Phase 1 and phase 2 results highlight promise of ADCs for hard-to-treat cancers

pharmatimes.com

October 20, 2025 at 1:43 PM

pharmaphorum

@pharmaphorum.bsky.social

#GSK has reported positive clinical results with an #antibodydrugconjugate licensed from China's #HansohPharma in 2023, delivering an early fillip for new chief executive Luke Miels.

pharmaphorum.com/news/data-ba...

April 13, 2026 at 10:04 AM

MSK Library

@msklibrary.bsky.social

Synapse: Your Connection to our MSK Authors.
Meet: Robin Guo
Research Focus: Medicine; Assistant Attending L1

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
synapse.mskcc.org/synapse/work...

#OvarianCancer #CancerResearch #AntibodyDrugConjugate

November 10, 2025 at 4:53 PM

Signal Transduction and Targeted Therapy

@sigtrans-sttt.bsky.social

Oncogenic #MUC1-C/M1C protein confers osimertinib resistance in #NSCLC cells by driving an inflammatory memory response via the STAT1/ IFN type I/II pathways and serves as a target for M1C #AntibodyDrugConjugate treatment. @harvardmed.bsky.social

#OpenAccess: doi.org/10.1038/s413...

December 23, 2025 at 6:25 PM

星良孝 Yoshitaka Hoshi

@yoshitakahoshi.bsky.social

第一三共、エンハーツが中国でHER2陽性胃がん二次治療に承認──DESTINY-Gastric04に基づく
ENHERTU (trastuzumab deruxtecan) approved in China for second-line HER2-positive gastric cancer based on DESTINY-Gastric04

stellanews.life/technology/8...

#GastricCancer #HER2 #ENHERTU #AntibodyDrugConjugate #DESTINYGastric04